F.S. Spallanzani

F.S. Spallanzani, operating as the National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, is a renowned institution dedicated to cutting-edge research and healthcare in the field of infectious diseases. Specializing in molecular characterization of viruses, particularly SARS-CoV-2, the institute plays a pivotal role in understanding and combating the spread of infectious pathogens. Their core services include genome sequencing, virus isolation, and analysis of viral quasispecies, providing valuable insights into the evolution and adaptation of viruses within hosts.

With a strong industry position and a global presence, F.S. Spallanzani stands out for its contributions to scientific knowledge and public health. The institute's commitment to sharing research data through initiatives like GISAID demonstrates their dedication to collaboration and transparency in the scientific community. Notable achievements include the successful isolation of SARS-CoV-2 from patient samples, as well as the identification of key genetic variants in the virus, essential for diagnostic updates and understanding viral evolution.

Founded on a mission to advance infectious disease research and provide high-quality healthcare, F.S. Spallanzani embodies a culture of excellence and innovation. Led by a team of experienced professionals, the institute upholds values of integrity, scientific rigor, and patient-centric care. Their strategic direction focuses on continuous research, genomic analysis, and collaboration with global partners to address emerging infectious disease challenges and improve public health outcomes. As a leading authority in infectious disease research, F.S. Spallanzani remains at the forefront of scientific discovery and medical advancements.